Wells Fargo & Company Agenus Inc Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$0.53 - $0.93 $21,784 - $38,224	-41,102 Reduced 4.06%	970,150 $562,000
Q4 2023 Feb 09, 2024	SELL	$0.63 - $1.14 $809,456 - $1.46 Million	-1,284,851 Reduced 55.96%	1,011,252 $839,000
Q3 2023 Nov 13, 2023	SELL	$1.12 - $1.88 $47,094 - $79,052	-42,049 Reduced 1.8%	2,296,103 $2.59 Million
Q2 2023 Aug 15, 2023	BUY	$1.31 - $2.04 $455,713 - $709,660	347,873 Added 17.48%	2,338,152 $3.74 Million
Q1 2023 May 12, 2023	BUY	$1.45 - $2.95 $1.04 Million - $2.12 Million	719,580 Added 56.63%	1,990,279 $3.03 Million
Q4 2022 Feb 13, 2023	SELL	$2.02 - $3.25 $130,197 - $209,475	-64,454 Reduced 4.83%	1,270,699 $3.05 Million
Q3 2022 Nov 14, 2022	SELL	$1.96 - $3.14 $118,084 - $189,175	-60,247 Reduced 4.32%	1,335,153 $2.74 Million
Q2 2022 Aug 12, 2022	BUY	$1.3 - $2.64 $280,868 - $570,379	216,053 Added 18.32%	1,395,400 $2.71 Million
Q1 2022 May 16, 2022	BUY	$2.35 - $3.47 $309,180 - $456,534	131,566 Added 12.56%	1,179,347 $2.9 Million
Q4 2021 Feb 14, 2022	SELL	$2.92 - $5.74 $200,636 - $394,401	-68,711 Reduced 6.15%	1,047,781 $3.37 Million
Q3 2021 Nov 15, 2021	BUY	$4.98 - $6.63 $206,201 - $274,521	41,406 Added 3.85%	1,116,492 $5.86 Million
Q2 2021 Aug 16, 2021	BUY	$2.56 - $5.49 $67,025 - $143,739	26,182 Added 2.5%	1,075,086 $5.9 Million
Q1 2021 May 13, 2021	SELL	$2.69 - $5.25 $322,743 - $629,889	-119,979 Reduced 10.26%	1,048,904 $2.85 Million
Q4 2020 Feb 09, 2021	SELL	$3.17 - $4.49 $104,254 - $147,667	-32,888 Reduced 2.74%	1,168,883 $3.72 Million
Q3 2020 Nov 05, 2020	SELL	$2.98 - $5.2 $80,758 - $140,920	-27,100 Reduced 2.21%	1,201,771 $4.81 Million
Q2 2020 Aug 13, 2020	BUY	$2.29 - $4.24 $231,232 - $428,134	100,975 Added 8.95%	1,228,871 $4.83 Million
Q1 2020 May 14, 2020	BUY	$1.92 - $4.39 $2.17 Million - $4.95 Million	1,127,896 New	1,127,896 $2.76 Million

Others Institutions Holding AGEN

# of Institutions

Shares Held

2.07M

Call Options Held

Put Options Held

View Full List

About AGENUS INC

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

More about AGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account